Switzerland is a leader in biotechnology innovation. Its geographic position, industry and the variety of academia and non-profit organizations have helped the country forge a unique cluster for the development of a dynamic biotech industry. This presentation focuses on existing and new regulations in the Swiss biotech sector and provides an overview of the impact of ongoing regulatory initiatives on biotech development (statistics), technology transfer successes and regional case studies in a federalistic country.

Learning Objectives:

  • Develop an understanding of the Swiss biotech sector
  • Gain knowledge on technology transfer methods in Switzerland
  • Discuss the Swiss financing environment and stock exchange and how they impact the biotech sector

Ability Level: Advanced

Session ID: 1948

myBIO Chatter

Speakers (2)

Dr. Tobias Ostler Tobias Ostler Immunologist, Senior Manager Scientific Affairs Biopharmaceuticals
User Juergen Regenold CEO regulanet

Moderators (1)

IMG_2198 Domenico Alexakis CEO Swiss Biotech Association